Michael Gajhede

14PUBLICATIONS
53CO-AUTHORS
Biologically active moleculesMolecular targetsCharacterisation of biological macromoleculesFree radical chemistryProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 21, 2025
Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction.

Chunyu Lin, Dilip Narayanan, Marilia Barreca

|May 07, 2025
Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer.

Anamarija Pfeiffer, Luca Di Leo, Marc Baker Bechmann

|Jan 08, 2025
Structural basis of THC analog activity at the Cannabinoid 1 receptor.

Thor S Thorsen, Yashraj Kulkarni, David A Sykes

|Oct 17, 2024
Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 Inhibitors.

Yuting Qin, Cecilie Poulsen, Dilip Narayanan

|Jun 03, 2024
Structural basis of Δ9-THC analog activity at the Cannabinoid 1 receptor.

David Gloriam, Thor Thorsen, Yashraj Kulkarni

|Dec 25, 2023
Small-molecule positive allosteric modulation of homomeric kainate receptors GluK1-3: development of screening assays and insight into GluK3 structure.

Yasmin Bay, Raminta Venskutonytė, Stine M Frantsen

Pageof 3

Frequent Collaborators

4 joint publications

Anders Bach

3 joint publications

David Olagnier

2 joint publications

Sarah E Jones

2 joint publications

David Gloriam